These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 4430447)
1. [Use of the system of progesterone liberation in uterol in dysfunctional uterine bleeding]. Ruiz Velasco V; Martínez Manautou J; Illanes Amurrio S; Maqueo Topete M; Conde de Vargas BI Ginecol Obstet Mex; 1974 Aug; 36(214):115-27. PubMed ID: 4430447 [TBL] [Abstract][Full Text] [Related]
2. [The intrauterine active disposition in the dysfunctional uterine bleeding: its action on miometrium, endometrium and vaginal epithelium]. Ruiz-velasco V; Martinez Manatau J; Illanes Amurrio S; Romero Salinas G; Maqueo Topete M; Conde De Varges BI J Bras Ginecol; 1974 Oct; 78(4):417-31. PubMed ID: 12278214 [TBL] [Abstract][Full Text] [Related]
3. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone. Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525 [TBL] [Abstract][Full Text] [Related]
4. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms. Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462 [TBL] [Abstract][Full Text] [Related]
5. Hysteroscopic evaluation of intrauterine progesterone contraceptive system as a treatment for abnormal uterine bleeding. Scarselli G; Mencaglia L; Tantini C; Colafranceschi M; Taddei G Acta Eur Fertil; 1984; 15(4):279-82. PubMed ID: 6240880 [TBL] [Abstract][Full Text] [Related]
6. [Clinical study on the effect of vaginal administration of micronized progesterone at dysfunctional uterine bleeding in premenopause]. Kostova P; Zlatkov V Akush Ginekol (Sofiia); 2009; 48(2):3-7. PubMed ID: 20198768 [TBL] [Abstract][Full Text] [Related]
7. Expression of angiotensin II and its receptor subtypes in endometrial hyperplasia: a possible role in dysfunctional menstruation. Li XF; Ahmed A Lab Invest; 1996 Aug; 75(2):137-45. PubMed ID: 8765314 [TBL] [Abstract][Full Text] [Related]
8. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)]. Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443 [TBL] [Abstract][Full Text] [Related]
9. [Management of abnormal bleeding in an intrauterine device user]. Desmons F; Adam-steen C Cah Sexol Clin; 1985; 11(63):185-7. PubMed ID: 12281357 [TBL] [Abstract][Full Text] [Related]
10. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy. Bourdrez P; Bongers MY; Mol BW Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006 [TBL] [Abstract][Full Text] [Related]
11. [The endometrium under the effects of hormone replacement therapy in menopause with percutaneous estradiol and low-dose micronized progesterone]. Philippe E; Faguer B; Engelman A; Charpin C; Loubière R; de Mascarel A; Leduc F; Dupin P; Hemet J; Vauzelle JL Pathologica; 1993; 85(1099):475-87. PubMed ID: 8127629 [TBL] [Abstract][Full Text] [Related]
12. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability]. Custo GM; Cosmi EV Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352 [TBL] [Abstract][Full Text] [Related]
13. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension. Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977 [TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system. Möller B; Rönnerdag M; Wang G; Odlind V; Olovsson M Hum Reprod; 2005 May; 20(5):1410-7. PubMed ID: 15760960 [TBL] [Abstract][Full Text] [Related]
15. [Changes in the endometrium caused by retrosteroid RO-4-8347]. Herzer H; Cavegn B; Stamm O; Siebenmann R Gynaecologia; 1969; 168(1):1-24. PubMed ID: 5821090 [No Abstract] [Full Text] [Related]
16. [Dysfunctional bleeding from the pathological and histological viewpoints]. Ulm R Zentralbl Gynakol; 1970 Aug; 92(33):1068-75. PubMed ID: 5520316 [No Abstract] [Full Text] [Related]
17. [Dysfunctional uterine bleeding. Hormonal management with chlormadinone acetate]. Olivas Mendoza G; Santos Martínez A; Corral Olaguez M; Iduñate y Carlos DM; Hernández Ayup S Ginecol Obstet Mex; 1978 Dec; 44(266):463-71. PubMed ID: 84774 [TBL] [Abstract][Full Text] [Related]
18. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive. Batzer FR J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195 [TBL] [Abstract][Full Text] [Related]
19. Vaginal bleeding in adolescents. Gidwani GP J Reprod Med; 1984 Jun; 29(6):417-20. PubMed ID: 6747972 [TBL] [Abstract][Full Text] [Related]
20. Intrauterine devices: an effective alternative to oral hormonal contraception. Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]